Latest Breaking News On - Department of hematology hematopoietic cell transplantation - Page 8 : vimarsana.com

Syndax Announces Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia Meets Primary Endpoint and Stopped Early for Efficacy Following Protocol-Defined Interim Analysis

– Trial met its primary endpoint with a CR/CRh rate of 23% at interim analysis of the pooled KMT2Ar AML and ALL cohorts (p-value = 0.0036); an additional 14%.

Michaela metzgerIbrahim aldossSharon klahreDepartment of hematology hematopoietic cell transplantationPharmaceuticals incEuropean commissionData monitoring committeeDivision of leukemiaExchange commissionSyndax pharmaceuticalsSyndax pharmaceuticals incDrug administrationPrnewswire syndax pharmaceuticals nasdaqInternational numberIndependent data monitoring committeeChief executive officer

Experts Highlight Their Biggest Takeaways from the 2023 SOHO Annual Meeting

Experts Highlight Their Biggest Takeaways from the 2023 SOHO Annual Meeting
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesYi linTycel phillipsStephenm ansellHarry erbaDepartment of medicineDepartment of oncologyDivision of lymphomaLeukemia programCar therapy program at mayo clinicDepartment of hematologyDivision of hematologic malignanciesDivision of hematologyDepartment of hematology hematopoietic cell transplantationDepartment of internal medicineFaculty development

Dr Phillips on the Use of Bispecific Antibodies and CAR T-Cell Therapy in MCL and FL

Tycel Phillips, MD, MPH, discusses the use of bispecific antibodies and CAR T-cell therapy across hematologic malignancies, including in patients with mantle cell lymphoma and follicular lymphoma.

United statesTycel phillipsUniversity of texas md anderson cancer centerDepartment of hematology hematopoietic cell transplantationDivision of lymphomaHematopoietic cell transplantationCancer centerCity of hopeMantle cell lymphomaOnclive tv

Dr Phillips on Treatment With Bispecific Antibodies and CAR T-Cell Therapy in MCL

Dr Phillips on Treatment With Bispecific Antibodies and CAR T-Cell Therapy in MCL
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Tycel phillipsDepartment of hematology hematopoietic cell transplantationDivision of lymphomaHematopoietic cell transplantation

Duarte s City of Hope awarded $8 million for prostate cancer research – San Gabriel Valley Tribune

The grant was one of several TACTICAL awards short for Therapy ACceleration To Intercept CAncer Lethality given out by the Prostate Cancer Foundation.

United statesUniversity of pennsylvaniaSaul pricemanTanya dorffDepartment of hematology hematopoietic cell transplantationTranslational sciences technologiesT cell therapeutics research laboratoryUniversity of pennsylvania perelman school medicineProstate cancer foundationNational cancer instituteGenitourinary disease programProstate cancerHematopoietic cell transplantationTranslational sciencesPennsylvania perelman schoolNational cancer